Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Du sparer 0% ift. normalprisen Spar 0%

Paperback
8-11 hverdage
1.691,95 kr.

Bag om Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy.

Vis mere

Sprog:
Engelsk

ISBN:
9789400795815

Forlag:
Springer

Indbinding:
Paperback

Sideantal:
426

Udgivet:
8. oktober 2012

Udgave:
2012

Størrelse:
235x155x22 mm.

Vægt:
658 g.

Leveringstid: 8-11 hverdage.
Forventet levering: 6. december 2024

Normalpris

BLACK NOVEMBER
1.691,95 kr. + Fragt
~~1.691,95 kr.~~

Medlemspris

1.641,95 kr.

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy.

Brugerbedømmelser af Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Andre købte også..

Find lignende bøger

Bogen Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics findes i følgende kategorier:

Business og læring

Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics - Bog

Beskrivelse af Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Brugerbedømmelser af Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

Gør som tusindvis af andre bogelskere